1
|
Nazli A, Qiu J, Tang Z, He Y. Recent Advances and Techniques for Identifying Novel Antibacterial Targets. Curr Med Chem 2024; 31:464-501. [PMID: 36734893 DOI: 10.2174/0929867330666230123143458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 10/30/2022] [Accepted: 11/11/2022] [Indexed: 02/04/2023]
Abstract
BACKGROUND With the emergence of drug-resistant bacteria, the development of new antibiotics is urgently required. Target-based drug discovery is the most frequently employed approach for the drug development process. However, traditional drug target identification techniques are costly and time-consuming. As research continues, innovative approaches for antibacterial target identification have been developed which enabled us to discover drug targets more easily and quickly. METHODS In this review, methods for finding drug targets from omics databases have been discussed in detail including principles, procedures, advantages, and potential limitations. The role of phage-driven and bacterial cytological profiling approaches is also discussed. Moreover, current article demonstrates the advancements being made in the establishment of computational tools, machine learning algorithms, and databases for antibacterial target identification. RESULTS Bacterial drug targets successfully identified by employing these aforementioned techniques are described as well. CONCLUSION The goal of this review is to attract the interest of synthetic chemists, biologists, and computational researchers to discuss and improve these methods for easier and quicker development of new drugs.
Collapse
Affiliation(s)
- Adila Nazli
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, P. R. China
| | - Jingyi Qiu
- Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, 266 Fangzheng Avenue, Chongqing, 400714, P. R. China
| | - Ziyi Tang
- Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, 266 Fangzheng Avenue, Chongqing, 400714, P. R. China
| | - Yun He
- Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, P. R. China
| |
Collapse
|
2
|
Yamasaki K, Tokuno M, Tsukigawa K, Nagatsuka Y, Nishi K, Otagiri M, Sato Y. Possible Involvement of Protein Binding Inhibition in Changes in Dexmedetomidine Concentration in Extracorporeal Circuits during Midazolam Use. Biol Pharm Bull 2024; 47:389-393. [PMID: 38325827 DOI: 10.1248/bpb.b23-00659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2024]
Abstract
It was recently reported that the dexmedetomidine concentration within the extracorporeal circuit decreases with co-administration of midazolam. In this study, we investigated whether displacement of dexmedetomidine by midazolam from the binding site of major plasma proteins, human serum albumin (HSA) and α1-acid glycoprotein (AAG), would increase levels of free dexmedetomidine that could be adsorbed to the circuit. Equilibrium dialysis experiments indicated that dexmedetomidine binds to a single site on both HSA and AAG with four times greater affinity than midazolam. Midazolam-mediated inhibition of the binding of dexmedetomidine to HSA and AAG was also examined. The binding of dexmedetomidine to these proteins decreased in the presence of midazolam. Competitive binding experiments suggested that the inhibition of binding by midazolam was due to competitive displacement at site II of HSA and due to non-competitive displacement at the site of AAG. Thus, our present data indicate that free dexmedetomidine displaced by midazolam from site II of HSA or from AAG is adsorbed onto extracorporeal circuits, resulting in a change in the dexmedetomidine concentration within the circuit.
Collapse
Affiliation(s)
- Keishi Yamasaki
- Faculty of Pharmaceutical Sciences, Sojo University
- DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University
| | | | - Kenji Tsukigawa
- Faculty of Pharmaceutical Sciences, Sojo University
- DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University
| | - Yuka Nagatsuka
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
| | - Koji Nishi
- Faculty of Pharmaceutical Sciences, Sojo University
- DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University
| | - Masaki Otagiri
- Faculty of Pharmaceutical Sciences, Sojo University
- DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University
| | - Yuhki Sato
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
| |
Collapse
|
3
|
Rogóż W, Pożycka J, Kulig K, Owczarzy A, Szkudlarek A, Maciążek-Jurczyk M. New look at the metabolism of nonsteroidal anti-inflammatory drugs: influence on human serum albumin antioxidant activity. J Biomol Struct Dyn 2023; 41:753-763. [PMID: 34871148 DOI: 10.1080/07391102.2021.2011784] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Body's homeostasis is dependent on many factors, such as maintaining balance between free radicals formation and degradation. Human serum albumin (HSA) also plays an important role in homeostasis. The aim of this study was thermodynamic analysis of the interaction between ketoprofen (KET), naproxen (NPX), diclofenac (DIC) and HSA, as well as the effect of drug-albumin binding on HSA antioxidant activity using calorimetric and spectrophotometric techniques. Based on the calorimetric analysis it has been shown that accompanied by hydrophobic interaction drugs-albumin binding is an exoenergetic reaction. All analyzed drugs and HSA showed the ability to react with free radicals such as a radical cation, formed as a result of the reaction between 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and potassium persulfate (K2S2O8). Using ABTS assay a synergistic effect of ketoprofen (KET) and naproxen (NPX) on HSA antioxidant activity was observed while the effect of diclofenac (DIC) binding with albumin was probably additive. Because some medications including KET, NPX and DIC belong to over the counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs), it is necessary to understand their influence on HSA antioxidant activity.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- W Rogóż
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Poland
| | - J Pożycka
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Poland
| | - K Kulig
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Poland
| | - A Owczarzy
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Poland
| | - A Szkudlarek
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Poland
| | - M Maciążek-Jurczyk
- Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Poland
| |
Collapse
|
4
|
Sharmeen S, Kyei I, Hatch A, Hage DS. Analysis of drug interactions with serum proteins and related binding agents by affinity capillary electrophoresis: A review. Electrophoresis 2022; 43:2302-2323. [PMID: 36250426 PMCID: PMC10098505 DOI: 10.1002/elps.202200191] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2022] [Revised: 09/17/2022] [Accepted: 10/05/2022] [Indexed: 11/06/2022]
Abstract
Biomolecules such as serum proteins can interact with drugs in the body and influence their pharmaceutical effects. Specific and precise methods that analyze these interactions are critical for drug development or monitoring and for diagnostic purposes. Affinity capillary electrophoresis (ACE) is one technique that can be used to examine the binding between drugs and serum proteins, or other agents found in serum or blood. This article will review the basic principles of ACE, along with related affinity-based capillary electrophoresis (CE) methods, and examine recent developments that have occurred in this field as related to the characterization of drug-protein interactions. An overview will be given of the various formats that can be used in ACE and CE for such work, including the relative advantages or weaknesses of each approach. Various applications of ACE and affinity-based CE methods for the analysis of drug interactions with serum proteins and other binding agents will also be presented. Applications of ACE and related techniques that will be discussed include drug interaction studies with serum agents, chiral drug separations employing serum proteins, and the use of CE in hybrid methods to characterize drug binding with serum proteins.
Collapse
Affiliation(s)
- Sadia Sharmeen
- Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
| | - Isaac Kyei
- Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
| | - Arden Hatch
- Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
| | - David S Hage
- Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
| |
Collapse
|
5
|
Peters M, Bockfeld D, Tamm M. Cationic Iridium(I) NHC‐Phosphinidene Complexes and Their Application in Hydrogen Isotope Exchange Reactions. Eur J Inorg Chem 2022. [DOI: 10.1002/ejic.202200148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Marius Peters
- Technische Universität Braunschweig: Technische Universitat Braunschweig Institut für Anorganische und Analytische Chemie GERMANY
| | - Dirk Bockfeld
- Technische Universität Braunschweig: Technische Universitat Braunschweig Institut für Anorganische und Analytische Chemie GERMANY
| | - Matthias Tamm
- Technische Universität Braunschweig Institut für Anorganische und Analytische Chemie Hagenring 30 38106 Braunschweig GERMANY
| |
Collapse
|
6
|
Holland JP, Gut M, Klingler S, Fay R, Guillou A. Photochemical Reactions in the Synthesis of Protein-Drug Conjugates. Chemistry 2019; 26:33-48. [PMID: 31599057 DOI: 10.1002/chem.201904059] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Indexed: 12/15/2022]
Abstract
The ability to modify biologically active molecules such as antibodies with drug molecules, fluorophores or radionuclides is crucial in drug discovery and target identification. Classic chemistry used for protein functionalisation relies almost exclusively on thermochemically mediated reactions. Our recent experiments have begun to explore the use of photochemistry to effect rapid and efficient protein functionalisation. This article introduces some of the principles and objectives of using photochemically activated reagents for protein ligation. The concept of simultaneous photoradiosynthesis of radiolabelled antibodies for use in molecular imaging is introduced as a working example. Notably, the goal of producing functionalised proteins in the absence of pre-association (non-covalent ligand-protein binding) introduces requirements that are distinct from the more regular use of photoactive groups in photoaffinity labelling. With this in mind, the chemistry of thirteen different classes of photoactivatable reagents that react through the formation of intermediate carbenes, electrophiles, dienes, or radicals, is assessed.
Collapse
Affiliation(s)
- Jason P Holland
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland
| | - Melanie Gut
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland
| | - Simon Klingler
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland
| | - Rachael Fay
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland
| | - Amaury Guillou
- Department of Chemistry, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland
| |
Collapse
|
7
|
Oukhatar F, Eliseeva SV, Bonnet CS, Placidi M, Logothetis NK, Petoud S, Angelovski G, Tóth É. Toward MRI and Optical Detection of Zwitterionic Neurotransmitters: Near-Infrared Luminescent and Magnetic Properties of Macrocyclic Lanthanide(III) Complexes Appended with a Crown Ether and a Benzophenone Chromophore. Inorg Chem 2019; 58:13619-13630. [DOI: 10.1021/acs.inorgchem.9b00887] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Fatima Oukhatar
- Centre de Biophysique Moléculaire, UPR 4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, Cedex 2, France
- Department of Physiology of Cognitive Processes and MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max-Planck-Ring 8, 72076 Tubingen, Germany
| | - Svetlana V. Eliseeva
- Centre de Biophysique Moléculaire, UPR 4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, Cedex 2, France
| | - Célia S. Bonnet
- Centre de Biophysique Moléculaire, UPR 4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, Cedex 2, France
| | - Matteo Placidi
- Department of Physiology of Cognitive Processes and MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max-Planck-Ring 8, 72076 Tubingen, Germany
| | - Nikos K. Logothetis
- Department of Physiology of Cognitive Processes and MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max-Planck-Ring 8, 72076 Tubingen, Germany
- Department of Imaging Science and Biomedical Engineering, University of Manchester, Manchester, M13 9PT, U.K
| | - Stéphane Petoud
- Centre de Biophysique Moléculaire, UPR 4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, Cedex 2, France
| | - Goran Angelovski
- Department of Physiology of Cognitive Processes and MR Neuroimaging Agents, Max Planck Institute for Biological Cybernetics, Max-Planck-Ring 8, 72076 Tubingen, Germany
| | - Éva Tóth
- Centre de Biophysique Moléculaire, UPR 4301, CNRS, Université d’Orléans, rue Charles Sadron, 45071 Orléans, Cedex 2, France
| |
Collapse
|
8
|
Valero M, Burhop A, Jess K, Weck R, Tamm M, Atzrodt J, Derdau V. Evaluation of a P,N-ligated iridium(I) catalyst in hydrogen isotope exchange reactions of aryl and heteroaryl compounds. J Labelled Comp Radiopharm 2018; 61:380-385. [PMID: 29271003 DOI: 10.1002/jlcr.3595] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2017] [Revised: 12/08/2017] [Accepted: 12/08/2017] [Indexed: 02/06/2023]
Abstract
We have developed a novel and efficient iridium-catalyzed hydrogen isotope exchange reaction method with secondary and tertiary sulfonamides at ambient temperatures. Furthermore N-oxides and phosphonamides have been successfully applied in hydrogen isotope exchange reactions with moderate to excellent deuterium introduction.
Collapse
Affiliation(s)
- Mégane Valero
- R&D, Integrated Drug Discovery, Isotope Chemistry and Metabolite Synthesis, Sanofi, Frankfurt/Main, Germany
| | - Annina Burhop
- R&D, Integrated Drug Discovery, Isotope Chemistry and Metabolite Synthesis, Sanofi, Frankfurt/Main, Germany
| | - Kristof Jess
- Institut für Anorganische und Analytische Chemie, Technische Universität Braunschweig, Braunschweig, Germany
| | - Remo Weck
- R&D, Integrated Drug Discovery, Isotope Chemistry and Metabolite Synthesis, Sanofi, Frankfurt/Main, Germany
| | - Matthias Tamm
- Institut für Anorganische und Analytische Chemie, Technische Universität Braunschweig, Braunschweig, Germany
| | - Jens Atzrodt
- R&D, Integrated Drug Discovery, Isotope Chemistry and Metabolite Synthesis, Sanofi, Frankfurt/Main, Germany
| | - Volker Derdau
- R&D, Integrated Drug Discovery, Isotope Chemistry and Metabolite Synthesis, Sanofi, Frankfurt/Main, Germany
| |
Collapse
|
9
|
Atzrodt J, Derdau V, Kerr WJ, Reid M. Deuterium- und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. Angew Chem Int Ed Engl 2018. [DOI: 10.1002/ange.201704146] [Citation(s) in RCA: 90] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Jens Atzrodt
- Isotope Chemistry and Metabolite Synthesis, Integrated Drug Discovery, Medicinal Chemistry; Industriepark Höchst, G876 65926 Frankfurt Deutschland
| | - Volker Derdau
- Isotope Chemistry and Metabolite Synthesis, Integrated Drug Discovery, Medicinal Chemistry; Industriepark Höchst, G876 65926 Frankfurt Deutschland
| | - William J. Kerr
- Department of Pure and Applied Chemistry, WestCHEM; University of Strathclyde; 295 Cathedral Street Glasgow Scotland G1 1XL Großbritannien
| | - Marc Reid
- Department of Pure and Applied Chemistry, WestCHEM; University of Strathclyde; 295 Cathedral Street Glasgow Scotland G1 1XL Großbritannien
| |
Collapse
|
10
|
Atzrodt J, Derdau V, Kerr WJ, Reid M. Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences. Angew Chem Int Ed Engl 2018; 57:1758-1784. [PMID: 28815899 DOI: 10.1002/anie.201704146] [Citation(s) in RCA: 403] [Impact Index Per Article: 67.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2017] [Revised: 07/27/2017] [Indexed: 12/19/2022]
Abstract
Hydrogen isotopes are unique tools for identifying and understanding biological and chemical processes. Hydrogen isotope labelling allows for the traceless and direct incorporation of an additional mass or radioactive tag into an organic molecule with almost no changes in its chemical structure, physical properties, or biological activity. Using deuterium-labelled isotopologues to study the unique mass-spectrometric patterns generated from mixtures of biologically relevant molecules drastically simplifies analysis. Such methods are now providing unprecedented levels of insight in a wide and continuously growing range of applications in the life sciences and beyond. Tritium (3 H), in particular, has seen an increase in utilization, especially in pharmaceutical drug discovery. The efforts and costs associated with the synthesis of labelled compounds are more than compensated for by the enhanced molecular sensitivity during analysis and the high reliability of the data obtained. In this Review, advances in the application of hydrogen isotopes in the life sciences are described.
Collapse
Affiliation(s)
- Jens Atzrodt
- Isotope Chemistry and Metabolite Synthesis, Integrated Drug Discovery, Medicinal Chemistry, Industriepark Höchst, G876, 65926, Frankfurt, Germany
| | - Volker Derdau
- Isotope Chemistry and Metabolite Synthesis, Integrated Drug Discovery, Medicinal Chemistry, Industriepark Höchst, G876, 65926, Frankfurt, Germany
| | - William J Kerr
- Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, 295 Cathedral Street, Glasgow, Scotland, G1 1XL, UK
| | - Marc Reid
- Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, 295 Cathedral Street, Glasgow, Scotland, G1 1XL, UK
| |
Collapse
|
11
|
Yamasaki K, Sato H, Minagoshi S, Kyubun K, Anraku M, Miyamura S, Watanabe H, Taguchi K, Seo H, Maruyama T, Otagiri M. The Binding of Silibinin, the Main Constituent of Silymarin, to Site I on Human Serum Albumin. Biol Pharm Bull 2017; 40:310-317. [PMID: 28250272 DOI: 10.1248/bpb.b16-00790] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Silibinin is the main constituent of silymarin, an extract from the seeds of milk thistle (Silybum marianum). Because silibinin has many pharmacological activities, extending its clinical use in the treatment of a wider variety of diseases would be desirable. In this study, we report on the binding of silibinin to plasma proteins, an issue that has not previously been extensively studied. The findings indicated that silibinin mainly binds to human serum albumin (HSA). Mutual displacement experiments using ligands that primarily bind to sites I and II clearly revealed that silibinin binds tightly and selectively to site I (subsites Ia and/or Ic) of HSA, which is located in subdomain IIA. Thermodynamic analyses suggested that hydrogen bonding and van der Waals interactions are major contributors to silibinin-HSA interactions. Furthermore, the binding of silibinin to HSA was found to be decreased with increasing ionic strength and detergent concentration of the media, suggesting that electrostatic and hydrophobic interactions are involved in the binding. Trp214 and Arg218 were identified as being involved in the binding of silibinin to site I, based on binding experiments using chemically modified- and mutant-HSAs. In conclusion, the available evidence indicates that silibinin binds to the region close to Trp214 and Arg218 in site I of HSA with assistance by multiple forces and can displace site I drugs (e.g., warfarin or iodipamide), but not site II drugs (e.g., ibuprofen).
Collapse
|
12
|
Burhop A, Weck R, Atzrodt J, Derdau V. Hydrogen-Isotope Exchange (HIE) Reactions of Secondary and Tertiary Sulfonamides and Sulfonylureas with Iridium(I) Catalysts. European J Org Chem 2017. [DOI: 10.1002/ejoc.201601599] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- Annina Burhop
- Sanofi-Aventis Deutschland GmbH; Integrated Drug Discovery; MedChem; Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst Frankfurt Germany
| | - Remo Weck
- Sanofi-Aventis Deutschland GmbH; Integrated Drug Discovery; MedChem; Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst Frankfurt Germany
| | - Jens Atzrodt
- Sanofi-Aventis Deutschland GmbH; Integrated Drug Discovery; MedChem; Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst Frankfurt Germany
| | - Volker Derdau
- Sanofi-Aventis Deutschland GmbH; Integrated Drug Discovery; MedChem; Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst Frankfurt Germany
| |
Collapse
|
13
|
Jess K, Derdau V, Weck R, Atzrodt J, Freytag M, Jones PG, Tamm M. Hydrogen Isotope Exchange with Iridium(I) Complexes Supported by Phosphine-Imidazolin-2-imine P,N Ligands. Adv Synth Catal 2017. [DOI: 10.1002/adsc.201601291] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Kristof Jess
- Institut für Anorganische und Analytische Chemie; Technische Universität Braunschweig; Hagenring 30 38106 Braunschweig Germany
| | - Volker Derdau
- Sanofi; R&D, Integrated Drug Discovery, Med. Chem., Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst 65926 Frankfurt am Main Germany
| | - Remo Weck
- Sanofi; R&D, Integrated Drug Discovery, Med. Chem., Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst 65926 Frankfurt am Main Germany
| | - Jens Atzrodt
- Sanofi; R&D, Integrated Drug Discovery, Med. Chem., Isotope Chemistry & Metabolite Synthesis; Industriepark Höchst 65926 Frankfurt am Main Germany
| | - Matthias Freytag
- Institut für Anorganische und Analytische Chemie; Technische Universität Braunschweig; Hagenring 30 38106 Braunschweig Germany
| | - Peter G. Jones
- Institut für Anorganische und Analytische Chemie; Technische Universität Braunschweig; Hagenring 30 38106 Braunschweig Germany
| | - Matthias Tamm
- Institut für Anorganische und Analytische Chemie; Technische Universität Braunschweig; Hagenring 30 38106 Braunschweig Germany
| |
Collapse
|
14
|
Enokida T, Yamasaki K, Okamoto Y, Taguchi K, Ishiguro T, Maruyama T, Seo H, Otagiri M. Tyrosine411 and Arginine410 of Human Serum Albumin Play an Important Role in the Binding of Sodium 4-Phenylbutyrate to Site II. J Pharm Sci 2016; 105:1987-1994. [PMID: 27113474 DOI: 10.1016/j.xphs.2016.03.012] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2016] [Revised: 02/26/2016] [Accepted: 03/10/2016] [Indexed: 12/22/2022]
Abstract
Sodium 4-phenylbutyrate (PB) has many pharmacological activities; therefore extending its clinical use to the treatment of a wider variety of diseases would be desirable. However, our knowledge of the binding of PB to plasma proteins is not extensive. To address this issue in more detail, we characterized the protein binding of PB. Binding experiments showed that PB mainly binds to human serum albumin (HSA) in plasma. PB was also found to bind to a single site on HSA, which was identified as site II by fluorescent probe displacement experiment. Furthermore, an appropriate alkyl chain length and a carboxylic group in the PB structure were required for PB binding to HSA, suggesting that hydrophobic (and van der Waals) and electrostatic interactions are involved as binding modes. The contributions of hydrogen bonding and/or van der Waals interactions were also indicated by thermodynamic analyses. Tyrosine411 and arginine410 were identified as being involved in the binding of PB to site II, based on binding experiments using chemically modified- and mutant-HSA preparations. In conclusion, the available evidence indicates that PB binds to site II of HSA with assistance by multiple forces and that tyrosine411 and arginine410 both play important roles in this phenomenon.
Collapse
Affiliation(s)
- Taisuke Enokida
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan
| | - Keishi Yamasaki
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan; DDS Research Institute, Sojo University, Kumamoto 860-0082, Japan.
| | - Yuko Okamoto
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan
| | - Kazuaki Taguchi
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan
| | - Takako Ishiguro
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan
| | - Toru Maruyama
- Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
| | - Hakaru Seo
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan; DDS Research Institute, Sojo University, Kumamoto 860-0082, Japan
| | - Masaki Otagiri
- Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan; DDS Research Institute, Sojo University, Kumamoto 860-0082, Japan.
| |
Collapse
|
15
|
Admas TH, Bernat V, Heinrich MR, Tschammer N. Development of Photoactivatable Allosteric Modulators for the Chemokine Receptor CXCR3. ChemMedChem 2016; 11:575-84. [PMID: 26880380 DOI: 10.1002/cmdc.201500573] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2015] [Indexed: 11/05/2022]
Abstract
The CXCR3 receptor, a class A G protein-coupled receptor (GPCR), is involved in the regulation and trafficking of various immune cells. CXCR3 antagonists have been proposed to be beneficial for the treatment of a wide range of disorders including but not limited to inflammatory and autoimmune diseases. The structure-based design of CXCR3 ligands remains, however, hampered by a lack of structural information describing in detail the interactions between an allosteric ligand and the receptor. We designed and synthesized photoactivatable probes for the structural and functional characterization, using photoaffinity labeling followed by mass spectrometry, of the CXCR3 allosteric binding pocket of AMG 487 and RAMX3, two potent and selective CXCR3 negative allosteric modulators. Photoaffinity labeling is a common approach to elucidate binding modes of small-molecule ligands of GPCRs through the aid of photoactivatable probes that convert to extremely reactive intermediates upon photolysis. The photolabile probe N-[({1-[3-(4-ethoxyphenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl]ethyl}-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-{1-[4-(3-(trifluoromethyl)-3H-diazirin-3-yl]benzyl}piperidin-4-yl)methyl]acetamide (10) showed significant labeling of the CXCR3 receptor (80%) in a [(3) H]RAMX3 radioligand displacement assay. Compound 10 will serve as an important tool compound for the detailed investigation of the binding pocket of CXCR3 by mass spectrometry.
Collapse
Affiliation(s)
- Tizita Haimanot Admas
- Department of Chemistry & Pharmacy, Emil Fischer Center, Friedrich Alexander University Erlangen-Nürnberg, Schuhstr. 19, 91052, Erlangen, Germany
| | - Viachaslau Bernat
- Department of Chemistry & Pharmacy, Emil Fischer Center, Friedrich Alexander University Erlangen-Nürnberg, Schuhstr. 19, 91052, Erlangen, Germany.,Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, 3A1, 33458, Jupiter, FL, USA
| | - Markus R Heinrich
- Department of Chemistry & Pharmacy, Emil Fischer Center, Friedrich Alexander University Erlangen-Nürnberg, Schuhstr. 19, 91052, Erlangen, Germany
| | - Nuska Tschammer
- Department of Chemistry & Pharmacy, Emil Fischer Center, Friedrich Alexander University Erlangen-Nürnberg, Schuhstr. 19, 91052, Erlangen, Germany. .,NanoTemper Technologies GmbH, Flößergasse 4, 81369, München, Germany.
| |
Collapse
|
16
|
Kumar V, Yarravarapu N, Lapinsky DJ, Perley D, Felts B, Tomlinson MJ, Vaughan RA, Henry LK, Lever JR, Newman AH. Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram. J Med Chem 2015; 58:5609-19. [PMID: 26153715 PMCID: PMC4515784 DOI: 10.1021/acs.jmedchem.5b00682] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
![]()
Three photoaffinity ligands (PALs)
for the human serotonin transporter
(hSERT) were synthesized based on the selective serotonin reuptake
inhibitor (SSRI), (S)-citalopram (1).
The classic 4-azido-3-iodo-phenyl group was appended to either the
C-1 or C-5 position of the parent molecule, with variable-length linkers,
to generate ligands 15, 22, and 26. These ligands retained high to moderate affinity binding (Ki = 24–227 nM) for hSERT, as assessed
by [3H]5-HT transport inhibition. When tested against Ser438Thr
hSERT, all three PALs showed dramatic rightward shifts in inhibitory
potency, with Ki values ranging from 3.8
to 9.9 μM, consistent with the role of Ser438 as a key residue
for high-affinity binding of many SSRIs, including (S)-citalopram. Photoactivation studies demonstrated irreversible adduction
to hSERT by all ligands, but the reduced (S)-citalopram
inhibition of labeling by [125I]15 compared
to that by [125I]22 and [125I]26 suggests differences in binding mode(s). These radioligands
will be useful for characterizing the drug–protein binding
interactions for (S)-citalopram at hSERT.
Collapse
Affiliation(s)
- Vivek Kumar
- †Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States
| | - Nageswari Yarravarapu
- ‡Division of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States
| | - David J Lapinsky
- ‡Division of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, United States
| | - Danielle Perley
- §Department of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, United States
| | - Bruce Felts
- §Department of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, United States
| | - Michael J Tomlinson
- §Department of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, United States
| | - Roxanne A Vaughan
- §Department of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, United States
| | - L Keith Henry
- §Department of Basic Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202, United States
| | - John R Lever
- ∥Department of Radiology, University of Missouri, One Hospital Drive, Columbia, Missouri 65212, United States.,⊥Harry S. Truman Memorial Veterans' Hospital, 800 Hospital Drive, Columbia, Missouri 65201, United States
| | - Amy Hauck Newman
- †Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States
| |
Collapse
|